Omaveloxolone promotes functional recovery of spinal cord injury by reducing inflammatory response and regulating macrophage polarization
Our results collectively confirm the efficacy of Omav in repairing spinal cord injury by targeting macrophage polarization and regulating inflammatory responses. This study not only highlights the therapeutic potential of Omav for SCI but also provides a novel pharmacological strategy for SCI treatment.
Authors
- Y. Zhang
- Junjin Li
- Dunxu Hu
- Zhuolin Wu
- Tao Zhang
- Pengtian Zhao
- Wenchao Dai
- Junbo Chen
- Erke Gao
- Baoyou Fan
- Wenlu Yuan
- Jiayi Zhang
- Zhijian Wei
- Dejing Zhang
Institutions
- Nankai University (CN)
- Tianjin First Center Hospital (CN)
- Tianjin Medical University General Hospital (CN)
- Second Hospital of Shandong University (CN)
- Shengli Oilfield Central Hospital (CN)
- Tianjin Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Molecular Neuroscience
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fnmol.2025.1737798
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00